In July 2013, Brasky and colleagues published a study that positively associated serum phospholipid omega-3 polyunsaturated fatty acids (PUFAs) with prostate cancer risk. We would like to raise some of our concerns about this study.
Suburu, J., Lim, K., Calviello, G., Chen, Y., RE: Serum phospholipid fatty acids and prostate cancer risk in the SELECT trial., <<JOURNAL OF THE NATIONAL CANCER INSTITUTE>>, 2014; 106 (4): N/A-N/A. [doi:10.1093/jnci/dju023] [http://hdl.handle.net/10807/64632]
RE: Serum phospholipid fatty acids and prostate cancer risk in the SELECT trial.
Calviello, Gabriella;
2014
Abstract
In July 2013, Brasky and colleagues published a study that positively associated serum phospholipid omega-3 polyunsaturated fatty acids (PUFAs) with prostate cancer risk. We would like to raise some of our concerns about this study.
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
